Pharmacologic Treatment of Primary Insomnia
Authors:
- Janine M. Hall-PorterJHJanine M. Hall-Porter
- D. Troy CurryDCD. Troy Curry
- James K. WalshJWJames K. Walsh
- 1 December 2010
- journal article
- review article
- Published by Elsevier in Sleep Medicine Clinics
- Vol. 5 (4) , 609-625
Abstract
No abstract availableThis publication has 159 references indexed in Scilit:
- Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomniaSleep Medicine, 2006
- An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomniaSleep Medicine, 2006
- Mammalian melatonin receptors: molecular biology and signal transductionCell and tissue research, 2002
- A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakeningBritish Journal of Clinical Pharmacology, 1999
- Sleepiness and performance during three-day administration of cetirizine or diphenhydramineJournal of Allergy and Clinical Immunology, 1994
- Treating Insomnia: Pharmacological and Nonpharmacological ApproachesJournal of Psychoactive Drugs, 1991
- Sensitivity to Triazolam in the ElderlyNew England Journal of Medicine, 1991
- Clinical Evaluation of Diphenhydramine Hydrochloride for the Treatment of Insomnia in Psychiatric Patients: A Double‐Blind StudyThe Journal of Clinical Pharmacology, 1990
- Diphenhydramine in Insomniac Family Practice Patients: A Double‐Blind StudyThe Journal of Clinical Pharmacology, 1983
- Psychological and physiological differences between good and poor sleepers.Journal of Abnormal Psychology, 1967